齐翔腾达(002408) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 was ¥6,873,242,466, a decrease of 14.15% compared to the same period last year[6]. - Net profit attributable to shareholders was ¥148,227,235.81, down 78.64% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥133,892,335.35, a decrease of 80.05%[6]. - The basic earnings per share for the quarter was ¥0.05, reflecting an 80.00% decline compared to the previous year[6]. - Total operating revenue for the current period is ¥23,278,380,523.33, a decrease of 9.2% from ¥25,755,541,024.23 in the previous period[23]. - Net profit for the current period is ¥1,039,249,455.58, a decline of 53.6% compared to ¥2,237,608,219.98 in the previous period[26]. - The total comprehensive income for the current period is ¥1,079,900,182.34, compared to ¥2,235,265,553.71 in the previous period, indicating a decrease of 51.7%[29]. Assets and Liabilities - Total assets increased to ¥28,556,481,638.61, representing a growth of 9.54% from the end of the previous year[6]. - The company's non-current assets totaled CNY 19.69 billion, an increase from CNY 17.11 billion, representing a growth of approximately 15.06%[20]. - The company's total liabilities increased to CNY 8.87 billion from CNY 7.96 billion, indicating a rise of about 11.43%[20]. - Total liabilities increased to ¥14,041,379,324.01 from ¥12,650,187,184.28, marking a growth of 10.9%[23]. - The company's total equity attributable to shareholders increased by 8.64% to ¥13,894,574,183.55 compared to the end of the previous year[6]. - Total equity attributable to shareholders of the parent company rose to ¥13,894,574,183.55 from ¥12,789,768,802.68, an increase of 8.7%[23]. Cash Flow - The company reported a net cash flow from operating activities of ¥1,353,262,895.03, which is a decrease of 11.19% year-to-date[6]. - The net cash flow from operating activities for the current period is CNY 1,353,262,895.03, a decrease of 11.15% compared to CNY 1,523,775,992.67 in the previous period[33]. - Total cash inflow from operating activities is CNY 25,193,244,413.87, down from CNY 25,996,353,360.49, reflecting a decline of 3.1%[33]. - Cash outflow from operating activities totaled CNY 23,839,981,518.84, compared to CNY 24,472,577,367.82 in the previous period, indicating a decrease of 2.6%[33]. - The net cash flow from investing activities is CNY -3,018,574,701.78, worsening from CNY -2,156,554,445.54 in the previous period[33]. - The net cash flow from financing activities increased to CNY 1,904,361,265.43, compared to CNY 927,367,373.15 in the previous period, showing an increase of 105.3%[33]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 78,474[12]. - The largest shareholder, Zibo Qixiang Petrochemical Group, holds 1,305,214,885 shares, accounting for 45.91% of the total shares[12]. - The second largest shareholder, Che Chengju, holds 105,027,091 shares, accounting for 3.69%[12]. - The top ten shareholders collectively hold a significant portion of the company's shares, with the largest three shareholders holding over 50%[12]. - The company has not disclosed any known relationships among the top ten shareholders, except for Che Chengju and Zibo Qixiang Petrochemical Group being acting in concert[12]. Investment and Financing Activities - A total of 2,990 million convertible bonds were issued, raising 2,990,000,000.00 RMB, with a net amount of 2,966,543,311.66 RMB after expenses[15]. - As of the end of the reporting period, 2,310,214,400 RMB (23,102,144 bonds) of the convertible bonds have been converted into 292,040,018 shares[15]. - The remaining amount of convertible bonds is 679,785,600 RMB, with 6,797,856 bonds left[15]. - The company has issued a total of 292,040,018 shares from the convertible bonds, with 26,974,600 shares coming from repurchased shares[15]. - The company’s stock is listed on the Shenzhen Stock Exchange under the bond name "Qixiang Convertible 2" with the code 128128[15]. Operational Changes - The company is in the process of a potential change in control, with PAGAC expressing intent to purchase all shares held by the controlling shareholder, despite ongoing judicial restrictions[16]. - The company has suspended the spin-off of its subsidiary, Shandong Qilu Keli Chemical Research Institute Co., Ltd., due to the impact of the controlling shareholder's equity transfer[16]. - The company has completed a comprehensive due diligence process with PAGAC and is cooperating on further documentation related to the share transfer[16]. Research and Development - Research and development expenses increased to ¥525,078,881.79 from ¥412,853,819.74, representing a rise of 27.2%[26].